Avery
- Company typePrivate
- Founded1970
- HeadquartersCommack, United States
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
Avery firmographics
Firmographics- Name
- Avery
- Legal name
- Avery Biomedical Devices, Inc.
- Website
- https://averybiomedical.com
- Company type
- Private
- Founded year
- 1970
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Ownership category
- akta.pro rank
Avery industry classification
Industry- Product category
- Implantable Medical Devices
- NAICS
- Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (33451)
- SIC
- Electromedical & Electrotherapeutic Apparatus (3845), Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Cardiac Rhythm Management (Pacemakers, ICDs, CRT) (HLAHAFAC)
- akta.pro secondary industries
- Sleep Apnea Therapy Devices (CPAP/APAP/BiPAP/ASV) (HLAHAGAA), Ventilators & Mechanical Ventilation Systems (ICU/Transport/Home) (HLAHAGAC)
Keywords
Where Avery is headquartered
LocationHeadquarters
- HQ city
- Commack
- HQ country
- United States
- HQ region
- North America
Offices7 records
Markets served
Avery business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Operations, Technology or R&D, Supply Chain, Marketing or Sales
Revenue model
- Medical Device Sales: Sale of the Avery Diaphragm Pacing System including implanted receivers, electrodes, external Spirit transmitter, and antennas. The system has a 10-year service life for Spirit transmitter and implanted receivers. Electrodes last the lifetime of the patient.
- Technical Support Services: Technical support provided at no additional cost. On-site support provided during each surgery. Virtual and on-site in-service training for hospital staff.
- Disposable Supplies: Annual replacement of external antennas and batteries. Less than $1,500 per year for disposable supplies.
- Insurance Reimbursement: Equipment is reimbursed by Medicare and many private and government insurance plans around the world. The company coordinates with insurance carriers for approval.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| One time/ perpetual license | Multi-year contract | Avery Diaphragm Pacing System with 10-year component service life |
| Unit Pricing | Annual | Disposable supplies (antennas and batteries) |
Go-to-market motion2 records
Distribution channels4 records
Marketing channels7 records
Avery product offering
Product offeringCore offering
Avery Biomedical Devices manufactures the Avery Diaphragm Pacing System, an implanted phrenic nerve stimulator consisting of surgically implanted receivers and electrodes paired with an external Spirit transmitter and antennas. The system delivers radiofrequency energy through intact skin to power implanted receivers, which stimulate the phrenic nerves to cause diaphragm contraction, providing chronic ventilatory support as an alternative to mechanical ventilation. The only diaphragm pacemaker with full FDA PMA approval and CE marking privileges for both adult and pediatric use.
Product overview
Avery Biomedical Devices offers a single unified product—the Avery Diaphragm Pacing System—which is an implanted phrenic nerve stimulator for providing chronic ventilatory support. The system consists of the Spirit Transmitter (external component worn by the patient) and surgically implanted receivers and electrodes. The device stimulates the phrenic nerves to cause diaphragm contraction, enabling natural breathing without mechanical ventilation. It is the only diaphragm pacemaker with full FDA PMA approval and CE marking privileges for both adult and pediatric patients with conditions including high spinal cord injury, central hypoventilation syndrome (CCHS), central sleep apnea, and diaphragm paralysis.
Differentiator
Problem solved
Functional benefit
Brands
- Avery Diaphragm Pacing System: Implanted phrenic nerve stimulator system consisting of surgically implanted receivers and electrodes and external transmitter and antennas for diaphragm pacing
- Spirit Transmitter
Products and services
- Avery Diaphragm Pacing System Implanted phrenic nerve stimulator (diaphragm pacemaker) system consisting of surgically implanted receivers and electrodes and an external transmitter with antennas. Provides chronic ventilatory support as an alternative to mechanical ventilation for patients with high spinal cord injury, CCHS, central sleep apnea, and diaphragm paralysis. Indicated for persons requiring chronic ventilatory support due to upper motor neuron respiratory muscle paralysis or central alveolar hypoventilation.
- Spirit Transmitter The external component of the Avery Diaphragm Pacing System that sends radiofrequency energy through intact skin to the implanted receivers. Worn with a belt or shoulder strap and powered by four AA alkaline batteries. Patients or caregivers can adjust amplitude and respiratory rate without special tools.
Quantifiable outcome
- Saves over $20,000 per year compared to mechanical ventilation ($1,500-$2,500/month vs. <$1,500/year for Avery)
- +4 more outcomes
Companies that use Avery
Customer profileNamed customers14 records
Segments5 records
Ideal customer profiles1 record
Avery technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature9 records
Avery partnerships and signals
Strategic signalPartnerships
14 partnerships are on record, tiered core and minor.
- George Washington University HospitalcoreMajor teaching hospital where Dr. Keith Mortman implanted Richard with the Avery Diaphragm Pacing System in August 2018.
- Dr. Mark E GinsburgcoreWorld-renowned Thoracic and Cardiovascular surgeon appointed to Avery's Board of Directors in July 2014. Has over 34 years of experience and has been implanting the Avery Diaphragm Pacing System since the late 1980s. Practices at NY Presbyterian Hospital and Good Samaritan Regional Medical Center.
- Dr. Don HeadleycoreOtolaryngologist (ENT) with almost 40 years of medical experience and over 20 years specifically with Avery Diaphragm Pacing Systems. Named Clinical Consultant to Avery Biomedical Devices in 2012. Affiliated with St. Joseph's Hospital and Medical Center in Phoenix, Arizona. Recognized by Healthgrades as a Healthgrades Choice Provider.
- CCHS NetworkcorePatient advocacy organization for Congenital Central Hypoventilation Syndrome families. CCHS Network logo appears on Avery's partner page indicating collaboration in patient education and awareness.
- Christopher and Dana Reeve FoundationcoreNonprofit organization focused on spinal cord injury research and quality of life. Their logo appears on Avery's partner page indicating collaboration in patient resources.
- United Spinal AssociationcoreOrganization dedicated to empowering people with spinal cord injuries and disorders. Logo appears on Avery's partner page indicating collaboration in patient education.
- Children's Hospital Los AngelescoreLeading pediatric hospital that has created a DVD presentation on their experience using the Avery Diaphragm Pacing System in CCHS patients through a grant from the Christopher and Dana Reeve Foundation. Actively implants Avery systems in children.
- Mesothelioma Veterans CenterminorResource center for veterans with mesothelioma. Logo appears on Avery's partner page indicating collaboration in veteran patient education.
- Amedtech SRLcoreExclusive representative for Avery Pacer in Argentina. Located at Olleros 2404 CP (1426), Buenos Aires, Argentina. Contact: Juan Santurian, Phone: (+54 11) 4777-9622.
- Bioingeniería SpAcoreExclusive representative for Avery Pacer in Chile. Located at Brasilera 0304, Punta Arenas, Chile. Contact: Carlos Fortune Cabello.
- Medihumana Colombia S.A.coreExclusive representative for Avery Pacer in Colombia. Located at Calle 90 # 19 A- 49 Oficina 706, Bogotá, Colombia. Contact: Línea en Bogotá: +57 (601) 611-4015.
- Lowenstein MedicalcoreExclusive representative for Avery Pacer in Israel. Contact: David Dagan, T: +972-8-9157877.
- ZAO Innotek MedicalcoreExclusive representative for Avery Pacer in Russia. Located at 1A, 4, Leninsky Prospect, 119049 Moscow, Russia. Contact: Edward Indilov, PhD, +7 (495) 215-18-68.
- Bridgeway Medical SystemscoreExclusive representative for Avery Pacer in United Arab Emirates. Located at 1st Floor, Al Ashram Building, Garhoud, Dubai. Contact: Riyas Rahman, Tel: +971 4282-2890.
Scale indicators8 records
Recent moves5 records
Expansion highlights5 records
Avery competitors and assessment
Company assessmentDirect peers
- Respicardia (ZOLL): Makes the remede System, an implanted phrenic nerve stimulator for central sleep apnea. Direct competitor in the same phrenic nerve stimulation category, though remede is approved only for adult CSA, not the broader SCI/CCHS indications Avery serves.
- Synapse Biomedical: Direct competitor with the NeuRx Diaphragm Pacing System, the other commercially available diaphragm pacemaker. Uses percutaneous electrodes rather than Avery's fully implantable RF approach. Only FDA-approved for adults 18+, making pediatric Avery's stronghold.
Others
- Fisher & Paykel Healthcare: Global respiratory care equipment manufacturer specializing in humidification, CPAP, and nasal interfaces. An adjacent player in the broader respiratory care ecosystem where Avery's diaphragm pacemakers serve as an alternative to non-invasive ventilation.
- Philips Respironics: Major manufacturer of mechanical ventilators, CPAP, and hospital respiratory care equipment. Represents the broader mechanical ventilation incumbent that Avery's diaphragm pacemaker displaces. Comparable as a competitor for respiratory care budgets and clinician mindshare.
- ResMed: Global leader in CPAP/BiPAP and mechanical ventilation equipment. Avery's device is a direct alternative to mechanical ventilation, so ResMed is the incumbent therapy whose patients represent Avery's primary switch opportunity. Not a direct competitor, but the dominant alternative therapy.
Broad incumbents
- Boston Scientific: Major player in cardiac rhythm management, spinal cord stimulators, and deep brain stimulation. Represents a potential strategic acquirer with neuromodulation expertise that could enter phrenic nerve stimulation or absorb Avery's clinical footprint.
- Medtronic: Global leader in implantable pulse generators, pacemakers, and neuromodulation devices. Avery operates in an adjacent niche (phrenic nerve) that Medtronic could enter with its existing IPG and neurostim capabilities, posing an indirect competitive threat.
- Nevro: Spinal cord stimulation company using implanted pulse generators. Comparable as an implanted neurostim business model targeting chronic conditions, though Nevro focuses on chronic pain rather than respiratory indications.
- LivaNova: Implantable neuromodulation company with vagus nerve stimulation and other neurostim platforms. Comparable as a peer in the implanted neurostimulator business model and regulatory/commercial pathway, though addressing different therapeutic targets.
- Inspire Medical Systems: Market leader in hypoglossal nerve stimulation for obstructive sleep apnea. While targeting OSA rather than central hypoventilation, Inspire represents the broader implanted neurostim approach for sleep-disordered breathing and a strategic reference point for Avery's neurostim business model.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights6 records
Customer concentration
Avery social profiles
Digital presenceAvery compliance and trust
Trust signalCompliance3 records
Avery financial estimates
Financial estimateRevenue estimate
Valuation estimate
Avery leadership team
Management profileNumber of profiles
Profiles2 records
Avery funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Avery M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Avery
What does Avery do?
Avery Biomedical Devices manufactures the Avery Diaphragm Pacing System, an implanted phrenic nerve stimulator consisting of surgically implanted receivers and electrodes paired with an external Spirit transmitter and antennas. The system delivers radiofrequency energy through intact skin to power implanted receivers, which stimulate the phrenic nerves to cause diaphragm contraction, providing chronic ventilatory support as an alternative to mechanical ventilation. The only diaphragm pacemaker with full FDA PMA approval and CE marking privileges for both adult and pediatric use.
Is Avery a public or private company?
Avery is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Avery founded?
Avery was founded in 1970. It employs 11 to 50 people.
Where is Avery based?
Avery is headquartered in Commack, United States, in the North America region.
How does Avery make money?
Four revenue lines are on record. Medical Device Sales are the primary driver. The others are technical Support Services, disposable Supplies and insurance Reimbursement.
Who are Avery's main competitors?
Direct peers on record are Respicardia (ZOLL) and Synapse Biomedical. Others are Fisher & Paykel Healthcare, Philips Respironics and ResMed. Broad incumbents are Boston Scientific, Medtronic, Nevro, LivaNova and Inspire Medical Systems.
Does Avery have an API?
No public API is recorded for Avery.
What industry is Avery in?
Avery's product category is Implantable Medical Devices. Its primary akta.pro industry code is HLAHAFAC, Cardiac Rhythm Management (Pacemakers, ICDs, CRT), with a secondary code of HLAHAGAA, Sleep Apnea Therapy Devices (CPAP/APAP/BiPAP/ASV). Its NAICS code is 334510 and its SIC code is 3845.